These results indicate that suppression of EGFR/HER2 signaling with Lapatinib inhibits AR activity in PCa cells and suggest the increased dependence of HER2 mediated AR activation in ENZR cells. This evidence concerns the gene ERBB2 and posterior cortical atrophy.